Related Experiment Videos
Neutralizing antibodies in slowly progressing HIV-1 infection
K Schønning1, C Nielsen, J Iversen
1Department of Infectious Diseases, Hvidovre Hospital, Denmark.
Summary
Individuals with slowly progressing human immunodeficiency virus type 1 (HIV-1) infection can neutralize their own virus. This ability is linked to lower viral loads and better CD4+ cell preservation.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection typically leads to progressive immune decline.
- Some individuals, termed slow progressors, maintain high CD4+ T-cell counts despite prolonged infection.
Purpose of the Study:
- To investigate the immunological and virological characteristics distinguishing slow progressors from rapid progressors of HIV-1 infection.
Main Methods:
- Comparison of CD4+ cell counts, proviral DNA load (using polymerase chain reaction), and virus isolation success rates between slow and rapid progressors.
- Assessment of viral phenotype (syncytia-inducing) and serum neutralizing antibody activity against autologous and heterologous HIV-1 strains.
Main Results:
- Slow progressors had significantly lower proviral loads and higher CD4+ cell counts than rapid progressors.
- Virus isolation was less successful in slow progressors, and their serum demonstrated potent neutralization of autologous HIV-1 strains, unlike rapid progressors.
- Neutralizing activity against heterologous strains (HIVMN, HIVIIIB) showed no significant difference or only a minor difference between groups.
Conclusions:
- Slowly progressing HIV-1 infection is associated with a distinct immunological profile, characterized by the ability to neutralize autologous viral strains.
- This autologous neutralization capacity may contribute to controlling viral replication and preserving immune function in slow progressors.